XHKG
8223
Market cap8mUSD
Oct 09, Last price
0.14HKD
1D
6.15%
1Q
-45.88%
IPO
-91.10%
Name
Ziyuanyuan Holdings Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ziyuanyuan Holdings Group Limited, an investment holding enterprise, primarily offers medical equipment finance leasing services across the People's Republic of China. The company's business activities are structured into distinct segments: Finance Leasing, Postpartum Care Services, and the Trade of Medical Equipment and Consumables. Within its finance leasing division, it extends both sale-leaseback and direct financing options, specifically targeting medium, small, and micro-sized businesses across diverse sectors such as printing, logistics, and transportation. Furthermore, Ziyuanyuan provides specialized care for mothers and infants post-delivery, alongside technological support and money lending facilities. Founded in 2014, the firm's main office is located in Shenzhen, PRC, functioning as a subsidiary of Hero Global Limited.
Key people
Junshen Zhang
Executive Chairman of the Board, Chief Executive Officer, Compliance Officer · since 2019
Xiangying Li
Joint Chief Financial Officer · since 2014
Dejun Du
Deputy General Manager, Business Development Director · since 2020
Peng Mou
Deputy General Manager, Risk Director · since 2019
Zhiwei Tian
Executive Director · since 2024
Kwok San Wong
Chief Financial Officer · since 2025
Xinpei Li
Joint Company Secretary, Non-Executive Director · since 2024
Di Lyu
Non-Executive Director · since 2019
Non-Executive Independent Director · since 2018
Siu Hang Chow
Non-Executive Independent Director · since 2018
Bin Deng
Non-Executive Independent Director · since 2021
Tao Hu
Non-Executive Independent Director · since 2025
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||